Bharat Parenterals Limited (NSE:BPLPHARMA)
India · Delayed Price · Currency is INR 1,800.80
-116.10 (-6.06%)
At close: Nov 9, 2026
Bharat Parenterals Market Cap
Bharat Parenterals has a market cap or net worth of 12.5 billion as of November 10, 2026. Its market cap has increased by 51.74% in one year.
Market Cap
12.50B
Enterprise Value
13.72B
Revenue
3.95B
Global Rank
n/a
Country Rank
n/a
PE Ratio
1,246.75
ChartMarket Cap Chart
Since March 21, 2018, Bharat Parenterals's market cap has increased from 914.45M to 12.50B, an increase of 1,266.67%. That is a compound annual growth rate of 35.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 12.50B | 49.93% |
| Dec 31, 2025 | 8.34B | -12.96% |
| Dec 31, 2024 | 9.58B | 103.12% |
| Dec 29, 2023 | 4.71B | 148.91% |
| Dec 30, 2022 | 1.89B | -13.76% |
| Dec 31, 2021 | 2.20B | 8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 19.37B |
| Syncom Formulations (India) | 18.85B |
| Amrutanjan Health Care | 14.95B |
| TTK Healthcare | 13.18B |
| Kopran | 12.53B |
| Bharat Parenterals | 12.50B |
| Fermenta Biotech | 12.36B |
| Lincoln Pharmaceuticals | 10.43B |